FK-506-13C-d2
|
|
- CAS-Nr.
- 1356841-89-8
- Englisch Name:
- FK-506-13C-d2
- Synonyma:
- TACROLIMUS (13C, 99%;Tacrolimus-13C;Tacrolimus-13C,D2 solution;Tacrolimus-13C, D2 (major);D2, 98%) 100 UG/ML IN ACETONITRILE;Methadone Hydrochloride Impurity 9;FK-506-13C,D2 (Major) (Tacrolimus)
(>FK-506-13C,D2 (Major) (Tacrolimus)(>85%);Fujimycin-13C,D2 Tacrolimus-13C D2 FK-506-13C,D2;Tacrolimus 13CD2Q: What is
Tacrolimus 13CD2 Q: What is the CAS Number of
Tacrolimus 13CD2 Q: What is the storage condition of
Tacrolimus 13CD2 Q: What are the applications of
Tacrolimus 13CD2
- CBNumber:
- CB93141783
- Summenformel:
- C44H67D2NO12
- Molgewicht:
- 807.039483556
- MOL-Datei:
- 1356841-89-8.mol
|
FK-506-13C-d2 Eigenschaften
- storage temp.
- -70°C
- L?slichkeit
- Chloroform: Slightly Soluble,Methanol: Slightly Soluble
- Aggregatzustand
- A solid
- Farbe
- White to yellow
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H301 |
Giftig bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P264, P270, P301+P310, P321, P330,P405, P501 |
|
Sicherheit |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
P301+P310 |
BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
P321 |
Besondere Behandlung |
P330 |
Mund ausspülen. |
P405 |
Unter Verschluss aufbewahren. |
P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
FK-506-13C-d2 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
FK-506-
13C-d
2 contains two deuterium atoms located on the carbon-13 bond. It is intended for use as an internal standard for the quantification of FK-506 by GC- or LC-MS. FK-506 is a potent, clinically-useful immunosuppressant in the same molecular class as cyclosporin A and rapamycin. Its mechanism of action involves the formation of a high affinity complex (K
i = 0.2 nM) with FK-
506 Binding Protein 12 (FKBP12). This complex then inhibits the activity of the calcium/calmodulin-dependent protein phosphatase, calcineurin, leading to disruption of T cell activation. The physiological effects of FK-506 also include regulation of nitric oxide neurotoxicity, neurotransmitter release, and regulation of Ca
2+ release
via the ryanodine and inositol-
(1,4,5)-
trisphosphate (IP
3) receptors. In the latter case, FKBP12 forms a tight complex with both ryanodine and IP
3 receptors which can be disrupted by FK-506, thereby rendering the receptors “l(fā)eaky” to Ca
2+.
Allgemeine Beschreibung
This stable-labeled internal standard is suited for quantitation of tacrolimus by LC/MS or GC/MS for clinical toxicology, therapeutic drug monitoring, or isotope dilution methods. Tacrolimus, also known as FK-506 or fujimycin, is an immunosuppressive drug marketed as Prograf, Advagraf, and Protopic usually used to prevent rejection of organ transplants and treatment of eczema. Use of a stable-labeled analog of tacrolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
FK-506-13C-d2 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FK-506-13C-d2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 31)Lieferanten
- (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-13C-d2)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
- Tacrolimus-13C
- Tacrolimus-13C,D2 solution
- TACROLIMUS (13C, 99%
- FK-506-13C,D2 (Major) (Tacrolimus)
(>
- (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl-3-13C-d2)-
- FK-506-13C,D2 (Major) (Tacrolimus)(>85%)
- D2, 98%) 100 UG/ML IN ACETONITRILE
- Tacrolimus 13CD2Q: What is
Tacrolimus 13CD2 Q: What is the CAS Number of
Tacrolimus 13CD2 Q: What is the storage condition of
Tacrolimus 13CD2 Q: What are the applications of
Tacrolimus 13CD2
- Fujimycin-13C,D2 Tacrolimus-13C D2 FK-506-13C,D2
- Tacrolimus-13C, D2 (major)
- Methadone Hydrochloride Impurity 9
- (1R,9S,12S,13R,14S,17S,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-[(3-13C,3,3-2H?)prop-2-en-1-yl]-11,28-dioxa-4-azatricyclo[22.3.1.0?,?]octacos-18-ene-2,3,10,16-tetrone
- 1356841-89-8
- C44H67D2NO12
- C43CH67D2NO12